Plasma interleukin-10 levels and adverse outcomes in acute coronary syndrome.

@article{Cavuolu2011PlasmaIL,
  title={Plasma interleukin-10 levels and adverse outcomes in acute coronary syndrome.},
  author={Erdal Cavuşoğlu and Jonathan D. Marmur and M. R. Hojjati and Vineet Chopra and Mitul Butala and Rakesh Subnani and Mohammad S Huda and Sunitha Yanamadala and Cyril Ruwende and Calvin A Eng and David J. Pinsky},
  journal={The American journal of medicine},
  year={2011},
  volume={124 8},
  pages={724-30}
}
UNLABELLED PURPOSE OR BACKGROUND: Interleukin (IL)-10 is an immunoregulatory cytokine that is produced by a variety of cell types, such as macrophages and activated monocytes. IL-10 possesses numerous anti-inflammatory, anti-thrombotic and anti-atherosclerotic properties. Furthermore, patients with acute coronary syndrome have been demonstrated to have reduced levels of IL-10 compared to their stable counterparts. For these reasons, it has been proposed that IL-10 plays a protective role in… CONTINUE READING